BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7645257)

  • 1. Secretion and antigenicity of hepatitis B virus small envelope proteins lacking cysteines in the major antigenic region.
    Mangold CM; Unckell F; Werr M; Streeck RE
    Virology; 1995 Aug; 211(2):535-43. PubMed ID: 7645257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Entry of hepatitis delta virus requires the conserved cysteine residues of the hepatitis B virus envelope protein antigenic loop and is blocked by inhibitors of thiol-disulfide exchange.
    Abou-Jaoudé G; Sureau C
    J Virol; 2007 Dec; 81(23):13057-66. PubMed ID: 17898062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the antigenic loop of the hepatitis B virus envelope proteins in infectivity of hepatitis delta virus.
    Jaoudé GA; Sureau C
    J Virol; 2005 Aug; 79(16):10460-6. PubMed ID: 16051838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutational analysis of the cysteine residues in the hepatitis B virus small envelope protein.
    Mangold CM; Streeck RE
    J Virol; 1993 Aug; 67(8):4588-97. PubMed ID: 8392600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunizations with chimeric hepatitis B virus-like particles to induce potential anti-hepatitis C virus neutralizing antibodies.
    Vietheer PT; Boo I; Drummer HE; Netter HJ
    Antivir Ther; 2007; 12(4):477-87. PubMed ID: 17668556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of mutations in the small envelope protein of hepatitis B virus on assembly and secretion of hepatitis delta virus.
    Jenna S; Sureau C
    Virology; 1998 Nov; 251(1):176-86. PubMed ID: 9813213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracellular retention of duck hepatitis B virus large surface protein is independent of preS topology.
    Gazina EV; Lin B; Gallina A; Milanesi G; Anderson DA
    Virology; 1998 Mar; 242(2):266-78. PubMed ID: 9514970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A conformational heparan sulfate binding site essential to infectivity overlaps with the conserved hepatitis B virus a-determinant.
    Sureau C; Salisse J
    Hepatology; 2013 Mar; 57(3):985-94. PubMed ID: 23161433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of HBs antigen negative variant of hepatitis B virus: unique substitutions, Glu129 to Asp and Gly145 to Ala in the surface antigen gene.
    Koyanagi T; Nakamuta M; Sakai H; Sugimoto R; Enjoji M; Koto K; Iwamoto H; Kumazawa T; Mukaide M; Nawata H
    Med Sci Monit; 2000; 6(6):1165-9. PubMed ID: 11208474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of complex B cell epitopes on woodchuck hepatitis virus surface antigens by using plasmids encoding chimeric proteins and DNA immunization.
    Zheng X; Schirmbeck R; Hilken G; Waters JA; Yang D; Reimann J; Roggendorf M; Lu M
    Virology; 2002 Mar; 294(2):342-53. PubMed ID: 12009876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the cytosolic domains of the hepatitis B virus envelope proteins for their function in viral particle assembly and infectivity.
    Blanchet M; Sureau C
    J Virol; 2006 Dec; 80(24):11935-45. PubMed ID: 17020942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a hepatitis B and hepatitis delta virus receptor binding site.
    Engelke M; Mills K; Seitz S; Simon P; Gripon P; Schnölzer M; Urban S
    Hepatology; 2006 Apr; 43(4):750-60. PubMed ID: 16557545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the reactivity pattern of murine monoclonal antibodies against wild-type hepatitis B surface antigen to G145R and other naturally occurring "a" loop escape mutations.
    Cooreman MP; van Roosmalen MH; te Morsche R; Sünnen CM; de Ven EM; Jansen JB; Tytgat GN; de Wit PL; Paulij WP
    Hepatology; 1999 Nov; 30(5):1287-92. PubMed ID: 10534351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of mutating the two cysteines required for HBe antigenicity on hepatitis B virus DNA replication and virion secretion.
    Bang G; Kim KH; Guarnieri M; Zoulim F; Kawai S; Li J; Wands J; Tong S
    Virology; 2005 Feb; 332(1):216-24. PubMed ID: 15661154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent developments in the diagnosis and monitoring of HBV infection and role of the genetic variability of the S gene.
    Weber B
    Expert Rev Mol Diagn; 2005 Jan; 5(1):75-91. PubMed ID: 15723594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of two hepatitis B virus populations isolated from a hepatitis B surface antigen-negative patient.
    Jeantet D; Chemin I; Mandrand B; Zoulim F; Trepo C; Kay A
    Hepatology; 2002 May; 35(5):1215-24. PubMed ID: 11981772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro characterization of viral fitness of therapy-resistant hepatitis B variants.
    Villet S; Billioud G; Pichoud C; Lucifora J; Hantz O; Sureau C; Dény P; Zoulim F
    Gastroenterology; 2009 Jan; 136(1):168-176.e2. PubMed ID: 18996386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoreactivity of HCV/HBV epitopes displayed in an epitope-presenting system.
    Chen Y; Xiong X; Liu X; Li J; Wen Y; Chen Y; Dai Q; Cao Z; Yu W
    Mol Immunol; 2006 Feb; 43(5):436-42. PubMed ID: 16337486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B virus infection after renal transplantation in the presence of antibody to hepatitis B surface antigen immunity.
    Kim KH; Ahn SH; Chung HY; Paik YH; Lee KS; Kim YS; Chon CY; Moon YM; Han KH
    J Gastroenterol Hepatol; 2004 Aug; 19(8):847-53. PubMed ID: 15242485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fine mapping of virus-neutralizing epitopes on hepatitis B virus PreS1.
    Maeng CY; Ryu CJ; Gripon P; Guguen-Guillouzo C; Hong HJ
    Virology; 2000 Apr; 270(1):9-16. PubMed ID: 10772975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.